TerminatedPhase 2 / Phase 3NCT01902823

Effect of Cancer Nurse Navigators on Patient Outcomes

There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued by cancer patients, but no studies have evaluated the effects of CNNs on important patient-reported outcomes or indicators of quality of care. This study has two aims: 1. To assess the feasibility of studying the impact of Aurora CNN Program. 2. To pilot test the effects of CNN services on patient-reported outcomes and indicators of quality of care.

Checked against the public recordLast updated Dec 13, 2019 · Source: ClinicalTrials.gov

StatusTerminated
PhasePhase 2 / Phase 3
U.S. locations2
SponsorUniversity of Wisconsin, Madison
01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Phase 2 / Phase 3
Sponsor
University of Wisconsin, Madison
Interventions being studied
Behavioral: Services from a Nurse Navigator
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: 1. Adult (18 years of age or older) 2. Treated at Aurora St. Luke's or West Allis Medical Center 3. New or recurrent dx of lung, prostate, colorectal or breast cancer - Exclusion Criteria: 1. Previously received CNN services at an Aurora treatment facility 2. Unable to read/write in English 3. Living in a nursing home/long term care facility 4. Not capable of completing study questionnaires -

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Aurora St. Luke's HospitalMilwaukee, Wisconsin
  • Aurora West AllisWest Allis, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 13, 2019. Always confirm current availability with the study team.

View original record ↗